Print 

asdsadsadsadsad

       It is known, that the medicines developed for treatment of diseases, have also side effects, sometimes dangerous for life. There are no absolutely safe medicines! Moreover, the use of medicines in a wide exposition may cause various adverse reactions of drugs (ADR) which were not registered during clinical trials because of the limited quota of the patients. Revealing, registration and analysis of the ADR (Pharmacovigilance) are necessary for the subsequent specification of the drugs' indications, contra-indications, side effects, dosages, etc. 

According to the Article 17 of the RA Law “On Drugs” “Health care institutions, drugstores, institutions and the organizations which are consuming and using medicines, are obliged to inform the authorized governmental body about all cases of development of unknown adverse reactions immediately”. 

According to the order of the Ministry of Health, which is an authorized governmental body, ADR monitoring in RA is carried out by the Scientific Centre of Drug and Medical Technologies Expertise, which has been a member of the WHO International Program of the ADR Monitoring (Uppsala, Sweden) since 1997.

For the purpose of ADR monitoring and according to the international recommendations, the Report Form for ADR registration has been developed at the centre, and it is being actively spread among the workers of public health services. 

Occupation 

The Report Form also contains the address of the recipient, as well as the fax and telephone number for emergency messages. 
You will help thousands of patients, if you do just a single simple thing: inform us about the suspected adverse drug reactions… 

Pharmacovigilance Department

HOT LINE: (+374 10) 20-05-05, (+374 96) 22-05-05

 
Download this file (23_N.PDF)Download[Order N23-N/17.05.2017/File available in armenian]
Download this file (ADRreport-NEW-English1.pdf)Download[Report Form]
Download this file (Pharmacovigilance Guideline_new.pdf)Download[Pharmacovigilance Guideline]